| Document Date: 2011-05-05 05:52:11
Open Document File Size: 486,29 KBShare Result on Facebook
City Stockholm / Roma / Stuttgart / Karachi / Parma / Genova / / Company Lang AE / Young AB / Chiesi Pharmaceuticals / Medtronic / Pearson / PET / Hershey / Creative Commons / Stereotaxis / Metalant AB / STN / Macmillan Publishers Limited / / Country Italy / Sweden / United States / / / Event Reorganization / Business Partnership / / Facility University of Tor Vergata / University of Minnesota / Lowered cAMP / / IndustryTerm subthalamic nucleus deep brain stimulation protocols / / MedicalCondition mean disease / JE / levodopa-induced dyskinesias / dyskinesia / decision-making and cognitive impairment / MS / Unified Parkinson’s Disease Rating scale / chronic nigrostriatal deafferentation / Disease / Parkinson disease / Complete sterility / Age (years) Disease / severe Parkinson’s disease / OFF dystonia / dyskinesias / movement disorders / Parkinson’s disease / dystonia / basal ganglia disorders / advanced Parkinson’s disease / / MedicalTreatment deep brain stimulation / deep brain stimulation surgery / neurosurgery / surgery / dialysis / / NaturalFeature Connel MT / / Organization University of Minnesota / Minneapolis / Functional / Local Ethics Committee / LD administration / University of Tor Vergata / / Person Tor Vergata / Arch Neurol / Angelo V / Ann Neurol / Primate / / / Position *Corresponding author / core player / neurologist / representative / / ProvinceOrState Minnesota / Virginia / South Dakota / / RadioStation Lozano AM / / Technology Neuroscience / shortened protocol / subthalamic nucleus deep brain stimulation protocols / neurosurgery / dialysis / / URL http /
SocialTag |
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus